Å·±¦ÓéÀÖ

“I discovered this tie several years ago when reporting on an FDA source’s tip about the suspected link between antiperspirants and breast cancer. The FDA official told me that the agency was contemplating requiring a breast cancer warning on antiperspirants based on several studies suggesting a possible link. But some inside the FDA felt that industry opposition would be insurmountable. It was an inside debate that would interest many in the public. As I pursued the story, the cosmetics industry wouldn’t do an interview but referred me to the American Cancer Society, which, they assured me, would defend their interests. Indeed, the American Cancer Society was all too happy to agree to appear on camera debunking any idea of a link between antiperspirants and breast cancer. But in my pre-interview with the Cancer Society’s chief doctor, I discovered he hadn’t read—and apparently didn’t know about—the latest peer-reviewed, published studies suggesting a link. That’s when I thought to ask the Cancer Society if it got funding from the cosmetics industry. The answer was a very defensive “Yes.â€� But the charity wouldn’t disclose how much and said they wouldn’t go through with the on-camera interview unless I agreed not to ask about the antiperspirant industry funding. I forwarded the studies to the American Cancer Society’s doctor. When he did the on-camera interview with me, he reversed his earlier position that had claimed the antiperspirant–breast cancer link was a “myth.â€� Instead, he answered my questions by deflecting—repeatedly stating, when asked about the latest antiperspirant studies, that women have more important things to focus on, such as getting regular mammograms.”
― Sharyl Attkisson, Stonewalled: One Reporter's Fight for Truth in Obama's Washington